Landmark TrialRCTRandomized Controlled Trial
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
New England Journal of Medicine2011IF: 25.4
Craig R. Smith, Martin B. Leon, Michael J. Mack, D. Craig Miller, Jeffrey W. Moses, Lars G. Svensson, E. Murat Tuzcu, John G. Webb, Gregory P. Fontana, Raj Makkar, Mathew Williams, Todd Dewey, Samir Kapadia, Vasilis Babaliaros, Vinod H. Thourani, Paul J. Corso, Augusto D. Pichard, Joseph E. Bavaria, Howard C. Herrmann, Jodi J. Akin, William N. Anderson, Duolao Wang, Stuart Pocock
Abstract
In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aortic-valve replacement were associated with similar rates of survival at 1 year, although there were important differences in periprocedural risks. (Funded by Edwards Lifesciences; Clinical Trials.gov number, NCT00530894.).